No Data
No Data
VNDA Rejects Second Takeover Bid by Cycle Group, Stock Rises
Cycle Pharmaceuticals Reaffirms Proposal to Acquire Vanda Pharmaceuticals
Sector Update: Health Care Stocks Higher Monday Afternoon
Vanda Pharmaceuticals Shares Rise; Cycle Pharmaceuticals' Buyout Offer Rejected Again
Vanda Pharmaceuticals: Cycle Offer 'Substantially Undervalues' Vanda
Express News | Vanda Pharmaceuticals Inc - Board Has Determined That Latest Proposal Is Not in Best Interests of Company or Stockholders